GILD - Gilead Sciences Inc. (GILD) RBC Capital Markets Global Healthcare Conference (Transcript)
2024-05-15 15:59:09 ET
Gilead Sciences, Inc. (GILD)
RBC Capital Markets Global Healthcare Conference
May 15, 2024 10:30 AM ET
Company Participants
Johanna Mercier - Chief Commercial Officer
Conference Call Participants
Brian Abrahams - RBC Capital Markets
Presentation
Brian Abrahams
Senior Biotech Analyst at RBC Capital Markets. We're really pleased to have our next presenting company, Gilead, represented by their Chief Commercial Officer, Johanna Mercier. Johanna, thanks again for joining us.
Johanna Mercier
Thanks, Brian, and hi, everybody. Good morning.
Question-and-Answer Session
Q - Brian Abrahams
So maybe we can kick things off on the HIV franchise. I know you've been in the space, you're the innovators in the space. You're the leaders. You've been there for such a long time. What are you seeing in terms of the intrinsic growth for the HIV franchise? And how should we think about go-forward growth contributors with regards to the overall market growth in both therapeutics and maybe also in PrEP market share growth and then pricing dynamics.
Johanna Mercier
Anything else? So let's talk a little bit about HIV and take a step back. And I think the HIV market is a really interesting one. And at Gilead, as you said, we've had the opportunity to be leaders because we've continuously innovated in this marketplace, and we will continue to do so. As I think about the market itself, I would split it between the treatment, the HIV treatment market and then the HIV prevention market....
Gilead Sciences, Inc. (GILD) RBC Capital Markets Global Healthcare Conference (Transcript)